Cholestyramine Resin

Cholestyramine Resin
Product Description

Treatment of hypercholesterolaemia: lowering of total and LDL-cholesterol levels in patients with primaryhypercholesterolaemia, including familial hypercholesterolaemia, or secondary as a supplement diet and other treatments, when the response to these measures proves inadequate.
Pruritus associated to partial biliary obstruction or primary biliary cirrhosis.

Diarrhea caused by bile acid malabsorrtion associated with Crohn's disease, intestinal resection,vagotomy, ot other conditions that cause excess bile acids in the intestine.

Dossier available as generic application. 

LABORATORIOS RUBIO SA

  • Country/Region:
    Spain
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    250 - 499
Company types
Manufacturer/Innovator
Primary activities
Pharmaceutical Company (generic finished products)
Specifications
  • Details
    Box containing 30/50 sachets of 4g.
  • Selling Points
    Experienced Technicians; Guarantee/Warranty; International Approvals/Standards; Packaging; Place of Origin; Price; Product Features; Product Performance; Prompt Delivery; Quality Service; Reputation
  • Model
    Sachets
  • Supplied from
    Spain
  • Measured In
    piece

LABORATORIOS RUBIO SA

  • Country/Region:
    Spain
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    250 - 499
Company types
Manufacturer/Innovator
Primary activities
Pharmaceutical Company (generic finished products)

More Products from LABORATORIOS RUBIO SA (13)

  • Methylphenidate Hydrochloride MR

    Product Methylphenidate Hydrochloride MR

    MR -  Treatment for children (over 6 years old), adolescents and adults with Attention Deficit Hyperactivity Disorder (ADHD). Box containing 30 capsules of 10/20/30/40/60 mg. Other packs are also available.

    Rubifen LA® is a bioequivalent generic of Ritalin LA® in the treatment of AD...
  • Guanfacine Hydrochloride

    Product Guanfacine Hydrochloride

    Guanfacine is indicated for the treatment of Attention Deficit and Hyperactivity Disorder (ADHD) in children and adolescents (6-17 years old) for whom stimulants are not suitable, not tolerated or have been shown to be ineffective.Guanfacine must be used as a part of a comprehensive ADHD treatment programm...
  • Lisdexamfetamine dimesylate

    Product Lisdexamfetamine dimesylate

    Treatment for Attention Deficit Hyperactivity Disorder (ADHD).

    It is used in children, young people, and adults who have previously taken a methylphenidate treatment that inadequately treated their ADHD.

    It is not used as a treatment for ADHD in children under 6 years of age b...
  • Melatonin 1mg/ml Oral Solution

    Product Melatonin 1mg/ml Oral Solution

    Sleep onset insomnia in children and adolescents (6-17 years of age) with attention deficit hyperactivity disorder (ADHD) where other healthy sleeping routines have not worked well enough.

    Short-term treatment of jet lag in adults.

    Strawberry flavour and contains Sorbitol.


    Bibliogr...
  • Melatonin 2mg prolonged -release

    Product Melatonin 2mg prolonged -release


    Monotherapy for the short-term treatment of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.
    Dose: 2 mg once daily, 1-2 hours before bedtime and after food. This dosage may be continued for up to thirteen weeks.

    Modified-release melatonin...
  • Tadalafil ODT

    Product Tadalafil ODT

    .Treatment of erectile dysfunction in adult males. 
    In order for tadalafil to be effective for the treatment of erectile dysfunction, sexual stimulation is required. 

    5 mg only: Treatment of the signs and symptoms of benign prostatic hyperplasia in adult males. 

    ...
  • Calcium Polystyrene Sulphonate

    Product Calcium Polystyrene Sulphonate

    Treatment and prevention of hyperkalaemia in adults and children.

    The product has showed efficacy in the reduction of potassium. 


    It is indicated for patients treated with dialysis with hyperkalaemia. 


    Sugar free product. Non-systemic absorption. 



    ...
  • Hydralazine Hydrochloride

    Product Hydralazine Hydrochloride

    Severe essential hypertension, when the oral route is not possible or a reduction in blood pressure is required urgently. Pre-eclampsia and eclampsia.
    Registered and marketed in Spain since 1984.


    CTD bibliographical dossier available.





  • Hydroxychloroquine Sulfate

    Product Hydroxychloroquine Sulfate

    ·         Rheumatoid Arthritis (joints inflammation)

    ·         Treatment of non-acute and non-complicate Malaria attacks and prevention of Malaria

    ·       &n...
  • OWLiver® Non-invasive metabolomic test for liver disease

    Product OWLiver® Non-invasive metabolomic test for liver disease

    The OWLiver® test is a serum-based non-invasive test for detecting MASLD, MASH with moderate or no fibrosis F0-F1, and MASH with significant fibrosis F≥2.OWLiver® has been validated against the gold standard liver biopsy. The OWLiver® test is based on metabolomic technology that determines the activit...
  • Methylphenidate Hydrochloride IR

    Product Methylphenidate Hydrochloride IR

    IR - Treatment for children (over 6 years old) and adolescents with Attention Deficit and Hyperactivity Disorder (ADHD).

    First Methylphenidate Hydrochloride launched in Spain (1983) with own trademark Rubifen®.

    Rubifen® is a bioequivalent generic of Ritalin® in the treatment of ...
  • Sodium Polystyrene Sulphonate

    Product Sodium Polystyrene Sulphonate

    Treatment and prevention of Hyperkalaemia in adults and children.

    The product has showed efficacy in the reduction of potassium.

    Sugar-free product. Non-systemic absorption.


LABORATORIOS RUBIO SA resources (1)